Functional Impact of GLP-1 for Heart Failure Treatment

Trial Profile

Functional Impact of GLP-1 for Heart Failure Treatment

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Mar 2017

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Acute heart failure
  • Focus Therapeutic Use
  • Acronyms FIGHT
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 14 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 16 Oct 2013 New source identified and integrated (Mayo Clinic, 12-009924).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top